UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Spontaneous acute superficial vein thrombosis of the legs: do we really need to treat?

Journal of thrombosis and haemostasis, 2015-06, Vol.13 (S1), p.S230-S237

2015

Volltextzugriff (PDF)

Annual diagnosis rate of superficial vein thrombosis of the lower limbs: the STEPH community‐based study

Journal of thrombosis and haemostasis, 2014-06, Vol.12 (6), p.831-838

2014

Volltextzugriff (PDF)

Assessment of clinically relevant bleeding as a surrogate outcome for major bleeding: validation by meta‐analysis of randomized controlled trials

Journal of thrombosis and haemostasis, 2017-08, Vol.15 (8), p.1547-1558

2017

Volltextzugriff (PDF)

Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery

British journal of surgery, 2001-07, Vol.88 (7), p.913-930

2001

Volltextzugriff (PDF)

Subcutaneous Fondaparinux versus Intravenous Unfractionated Heparin in the Initial Treatment of Pulmonary Embolism

The New England journal of medicine, 2003-10, Vol.349 (18), p.1695-1702

2003

Volltextzugriff (PDF)

Superficial vein thrombosis and recurrent venous thromboembolism: a pooled analysis of two observational studies

Journal of thrombosis and haemostasis, 2012-06, Vol.10 (6), p.1004-1011

2012

Volltextzugriff (PDF)

Superficial thrombophlebitis of the legs: still a lot to learn

Journal of thrombosis and haemostasis, 2005-06, Vol.3 (6), p.1149-1151

2005

Volltextzugriff (PDF)

Prevention of venous thromboembolism in orthopedic surgery with vitamin K antagonists: a meta‐analysis

Journal of thrombosis and haemostasis, 2004-07, Vol.2 (7), p.1058-1070

2004

Volltextzugriff (PDF)

Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

The New England journal of medicine, 2017-03, Vol.376 (13), p.1211-1222

2017

Volltextzugriff (PDF)

Fondaparinux for the Treatment of Superficial-Vein Thrombosis in the Legs

The New England journal of medicine, 2010-09, Vol.363 (13), p.1222-1232

2010

Volltextzugriff (PDF)

Fondaparinux for the Treatment of Superficial-Vein Thrombosis in the Legs

Journal of vascular surgery, 2011, Vol.53 (2), p.549-550

2011

Volltextzugriff (PDF)

Thrombin generation and heparin‐induced thrombocytopenia

Journal of thrombosis and haemostasis, 2009-09, Vol.7 (9), p.1474-1481

2009

Volltextzugriff (PDF)

Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials

Journal of thrombosis and haemostasis, 2007-06, Vol.5 (6), p.1191-1194

2007

Volltextzugriff (PDF)

Oral Rivaroxaban for Symptomatic Venous Thromboembolism

The New England journal of medicine, 2010-12, Vol.363 (26), p.2499-2510

2010

Volltextzugriff (PDF)

Superficial Venous Thrombosis and Venous Thromboembolism A Large, Prospective Epidemiologic Study

Journal of vascular surgery, 2010, Vol.52 (6), p.1727-1728

2010

Volltextzugriff (PDF)

Value of a Planned Compression Ultrasonography after an Isolated Superficial Vein Thrombosis: Results from a Prospective Multicentre Study

European journal of vascular and endovascular surgery, 2012-02, Vol.43 (2), p.233-237

2012

Volltextzugriff (PDF)

Superficial venous thrombosis and venous thromboembolism: a large, prospective epidemiologic study

Annals of internal medicine, 2010-02, Vol.152 (4), p.218

2010

Volltextzugriff (PDF)

Superficial thrombophlebitis of the legs: still a lot to learn. Reply to a rebuttal

Journal of thrombosis and haemostasis, 2006-01, Vol.4 (1), p.290-290

2006

Volltextzugriff (PDF)

Anti‐factor Xa activity of enoxaparin administered at prophylactic dosage to patients over 75 years old

British journal of clinical pharmacology, 2007-10, Vol.64 (4), p.428-438

2007

Volltextzugriff (PDF)

Compliance and stability of INR of two oral anticoagulants with different half-lives: a randomised trial

Thrombosis and haemostasis, 2003-03, Vol.89 (3), p.458-467

2003

Volltextzugriff (PDF)

Treatment of proximal deep vein thrombosis with a novel synthetic compound (SR90107A/ORG31540) with pure anti-factor Xa activity : A phase II evaluation

Circulation (New York, N.Y.), 2000-11, Vol.102 (22), p.2726-2731

2000

Volltextzugriff (PDF)

Clinical Predictors for Fatal Pulmonary Embolism in 15,520 Patients with Venous Thromboembolism: Findings from the Registro Informatizado de la Enfermedad Thrombo Embolica Venosa (RIETE) Registry

Journal of vascular surgery, 2008, Vol.48 (4), p.1063-1063

2008

Volltextzugriff (PDF)

O9 Fondaparinux 2.5 mg for the treatment of symptomatic, isolated superficial thrombophlebitis (ST): preliminary baseline data from the randomized placebo-controlled CALISTO trial

Thrombosis research, 2009, Vol.123, p.S133-S134

2009

Volltextzugriff (PDF)

Aging and venous thromboembolism influence the pharmacodynamics of the anti-factor Xa and anti-thrombin activities of a low molecular weight heparin (nadroparin)

Thrombosis and haemostasis, 1998-06, Vol.79 (6), p.1162-1165

1998

Volltextzugriff (PDF)

Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial

Annals of internal medicine, 2004-06, Vol.140 (11), p.867

2004

Volltextzugriff (PDF)

1 – 25 von 220

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(169)
Mit Volltextzugriff
(136)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Spontaneous acute superficial vein thrombosis of the legs: do we really need to treat?

Annual diagnosis rate of superficial vein thrombosis of the lower limbs: the STEPH community‐based study

Assessment of clinically relevant bleeding as a surrogate outcome for major bleeding: validation by meta‐analysis of randomized controlled trials

Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery

Subcutaneous Fondaparinux versus Intravenous Unfractionated Heparin in the Initial Treatment of Pulmonary Embolism

Superficial vein thrombosis and recurrent venous thromboembolism: a pooled analysis of two observational studies

Superficial thrombophlebitis of the legs: still a lot to learn

Prevention of venous thromboembolism in orthopedic surgery with vitamin K antagonists: a meta‐analysis

Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

Fondaparinux for the Treatment of Superficial-Vein Thrombosis in the Legs

Fondaparinux for the Treatment of Superficial-Vein Thrombosis in the Legs

Thrombin generation and heparin‐induced thrombocytopenia

Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials

Oral Rivaroxaban for Symptomatic Venous Thromboembolism

Superficial Venous Thrombosis and Venous Thromboembolism A Large, Prospective Epidemiologic Study

Value of a Planned Compression Ultrasonography after an Isolated Superficial Vein Thrombosis: Results from a Prospective Multicentre Study

Superficial venous thrombosis and venous thromboembolism: a large, prospective epidemiologic study

Superficial thrombophlebitis of the legs: still a lot to learn. Reply to a rebuttal

Anti‐factor Xa activity of enoxaparin administered at prophylactic dosage to patients over 75 years old

Compliance and stability of INR of two oral anticoagulants with different half-lives: a randomised trial

Treatment of proximal deep vein thrombosis with a novel synthetic compound (SR90107A/ORG31540) with pure anti-factor Xa activity : A phase II evaluation

Clinical Predictors for Fatal Pulmonary Embolism in 15,520 Patients with Venous Thromboembolism: Findings from the Registro Informatizado de la Enfermedad Thrombo Embolica Venosa (RIETE) Registry

O9 Fondaparinux 2.5 mg for the treatment of symptomatic, isolated superficial thrombophlebitis (ST): preliminary baseline data from the randomized placebo-controlled CALISTO trial

Aging and venous thromboembolism influence the pharmacodynamics of the anti-factor Xa and anti-thrombin activities of a low molecular weight heparin (nadroparin)

Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial

Suchergebnisse filtern